Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness
In Good Company with Nicolai Tangen
00:00
Innovating Through Transformation
This chapter delves into the strategic shift of a major pharmaceutical company as it transitions from a conglomerate to a focused innovator in medicines. It highlights the process of divesting non-core segments and prioritizing research and development in key therapeutic areas, supported by advanced technologies like AI and gene therapies. The discussion underscores the complexities of drug development in various healthcare domains and the promising advancements that could reshape future treatment options.
Transcript
Play full episode
